MiR-125b regulates osteogenic differentiation of human bone marrow mesenchymal stem cells by targeting Smad4

Journal of Central South University (Medical Sciences)

Volumn 38, Issue 4, 2013, Pages 341-346

  Lu, Xihong ^a   Deng, Min ^b   He, Honghui ^a   Zeng, Dehui ^a   Zhang, Wei ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Mesenchymal stem cells; MiR 125b; Osteogenic differentiation; Smad4

Indexed keywords

MESSENGER RNA; MICRORNA; MIRN125 MICRORNA, HUMAN; RUNX2 PROTEIN, HUMAN; SMAD4 PROTEIN; SMAD4 PROTEIN, HUMAN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DOWN REGULATION; FEMALE; GENETIC TRANSFECTION; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; OSTEOBLAST; PHYSIOLOGY; YOUNG ADULT;

BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DOWN-REGULATION; FEMALE; HUMANS; MESENCHYMAL STROMAL CELLS; MICRORNAS; OSTEOBLASTS; OSTEOGENESIS; RNA, MESSENGER; RNA, SMALL INTERFERING; SMAD4 PROTEIN; TRANSFECTION; YOUNG ADULT;

EID: 84878163063     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2013.04.002     Document Type: Article

References (14)

1. Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers [J]. Mol Cancer, 2007, 6:60.
2. Chen B, Li H, Zeng X, et al. Roles of microRNA on cancer cell metabolism [J]. J Transl Med, 2012, 10:228.
3. Wang Y, Yu Y, Tsuyada A, et al. Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through nuRNA-181 and ATM [J]. Oncogene, 2011, 30(12):1470-1480.
4. McDermott SP, Wicha MS. Targeting breast cancer stem cells [J]. Mol Oncol, 2010, 4(5):404-419.
5. Wu T, Zhou H, Hong Y, et al. miR-30 family members negatively regulate osteoblast differentiation [J]. J Biol Chem, 2012, 287(10):7503-7511.
6. Mizuno Y, Yagi K, Tokuzawa Y, et al. miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation [J]. Biochem Biophys Res Commun, 2008, 368(2):267-272.
7. MA Zhangwen, DU Shengli, TIAN Hongying, et al. The effect of miR-125b on MSCs osteoblastic differentiation [J]. Journal of Qiqihar University of Medicine, 2011, 32(4):512-513.
8. Yamamoto N, Akiyama S, Katagiri T, et al. Smadl and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts[J]. Biochem Biophys Res Commun, 1997, 238(2):574-580. (Pubitemid 27464430)
9. Pagani F, Francucci CM, Moro L. Markers of bone turnover: biochemical and clinical perspectives [J]. J Endocrinol Invest, 2005, 28(10 Suppl)):8-13.
10. Gheisari Y, Soleimani M, Azadmanesh K, et al. Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods [J]. Cytotherapy, 2008, 10(8):815-823.
11. Dominguez-Bendala J, Lanzoni G, Inverardi L, et al. Concise review: mesenchymal stem cells for diabetes [J]. Stem Cells Transl Med, 2012, 1(1):59-63.
12. Otsuru S, Gordon PL, Shimono K, et al. Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms [J]. Blood, 2012, 120(9):1933-1941.
13. Chen K, Aenlle KK, Curtis KM, et al. Hepatocyte growth factor (HGF) and 1, 25-dihydroxyvitamin D together stimulate human bone marrow-derived stem cells toward the osteogenic phenotype by HGF-induced up-regulation of VDR [J]. Bone, 2012, 51(1):69-77.
14. Laine SK, Hentunen T, Laitala-Leinonen T. Do microRNAs regulate bone marrow stem cell niche physiology? [J]. Gene, 2012, 497(1):1-9.